@entity1005 , mood disorders, and quality of life in transplant recipients with XXXX .

@entity1 @entity308 @entity879 @entity1005 @entity148 @entity99
OBJECTIVE: The objective of this study was to assess @entity1005 ( @entity1005 ), @entity308 , @entity148 , and quality of life among acute @entity99 @entity1 undergoing liver transplantation. METHOD: Twenty-four @entity1 underwent transplantation due to @entity879 . After a brief anamnestic interview to gather demographic and clinical information, each @entity1 underwent a psychological assessment using the SF-36 Health Survey (SF-36), Impact of Events Scale-Revised (IES-R), @entity148 and @entity308 (HAD) Scale, as well as Beck @entity308 Inventory (BDI). RESULTS: The average age of the @entity1 was 41.17 years (  17.03); the mean time after transplantation was 13.50    13.80 months; 83% of the subjects were @entity1 . @entity148 symptoms were observed in 33.2% of the @entity1 and @entity308 in 16.7% by HAD and 45.8% by BDI. By IES-R 46.2% of @entity1 presented high to severe levels of stress. The majority of @entity1 (54.2%) showed good quality of life scores. A correlation analysis indicated a significant negative association between SF-36 score and other scales (from -0.514 to -0.681). Upon a comparative analysis, a significant difference between groups was only noted in SF-36 score (P = .032). CONCLUSION: The results led us to conclude that @entity148 , @entity308 , and @entity1005 were negatively associated with quality of life in this population. These symptoms also contributed directly to determine well-being among these @entity1 .
